# Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors

> **NCT00547131** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors
- Metastatic Cancer

## Interventions

- **DRUG:** temozolomide
- **OTHER:** laboratory biomarker analysis
- **OTHER:** liquid chromatography
- **OTHER:** mass spectrometry
- **OTHER:** pharmacological study
- **PROCEDURE:** conventional surgery
- **RADIATION:** stereotactic radiosurgery

## Key facts

- **NCT ID:** NCT00547131
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2008-05
- **Final completion:** 2009-05
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2018-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00547131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00547131, "Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00547131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*